A detailed history of D. E. Shaw & Co., Inc. transactions in Schrodinger, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 50,900 shares of SDGR stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,900
Holding current value
$1.06 Million
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.65 - $28.5 $268,522 - $410,343
14,398 New
14,398 $278,000
Q4 2022

Feb 14, 2023

BUY
$16.24 - $26.38 $754,883 - $1.23 Million
46,483 New
46,483 $868,000
Q4 2020

Feb 16, 2021

SELL
$48.06 - $84.4 $4.09 Million - $7.18 Million
-85,039 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$46.87 - $93.33 $71.1 Million - $141 Million
-1,516,008 Reduced 94.69%
85,039 $4.04 Million
Q1 2020

May 15, 2020

BUY
$26.6 - $52.99 $42.6 Million - $84.8 Million
1,601,047 New
1,601,047 $69 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.29B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.